N/A
N/A
N/A
N/A
N/A
Open (Enrolling)
Both
Lymphoma, Non-Hodgkin, Hodgkin Disease
Both
Lymphoma, Non-Hodgkin, Hodgkin Disease
Trial Information
Inclusion Criteria:
- Patients with NHL and HD undergoing HDC and ASCT
Type of Study:
Interventional
Study Design:
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
Prognosis
Outcome Time Frame:
overall
Safety Issue:
No
Principal Investigator
Syed Akhtar, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
KFSH & RC
Authority:
United States: Institutional Review Board
Study ID:
RAC#2041-050
NCT ID:
NCT00534989
Start Date:
September 2007
Completion Date:
December 2013
Related Keywords:
- Lymphoma, Non-Hodgkin
- Hodgkin Disease
- NHL and HD
- Hodgkin Disease
- Lymphoma
- Lymphoma, Non-Hodgkin
Name | Location |
|---|
